ETOPOSIDE (VP-16-213)ISSELL BF; CROOKE ST.1979; CANCER TREATM. REV.; GBR; DA. 1979; VOL. 6; NO 2; PP. 107-124; BIBL. 70 REF.Article

INTERNATIONAL SYMPOSIUM ON THE PODOPHYLLOTOXINS IN CANCER THERAPY, SOUTHAMPTON, ENGLAND, JULY 8-9, 1981CARTER SK ED; MATHE G ED; MCELWAIN T ED et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 7; NO 2-3; 163 P.; BIBL. DISSEM.Conference Paper

CLINICAL TRIAL OF THE ORAL FORM OF A NEW PODOPHYLLATOXIN DERIVATIVE, VP-16-213 (NSC-141540), IN PATIENTS WITH ADVANCED NEOPLASTIC DISEASE.NISSEN NI; HANSEN HH; PEDERSEN H et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 5; PP. 1027-1029; BIBL. 5 REF.Article

EPEG, A NEW ANTINEOPLASTIC EPIPODOPHYLLOTOXIN.CREAVEN PJ; ALLEN LM.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 2; PP. 221-226; BIBL. 8 REF.Article

Flow cytometric fluorescence pulse width analysis of etoposide-induced nuclear enlargement in HCT116 cellsKYUNGSU KANG; SAET BYOUL LEE; YOO, Ji-Hye et al.Biotechnology letters. 2010, Vol 32, Num 8, pp 1045-1052, issn 0141-5492, 8 p.Article

TERATOGENIC AND CYTOGENIC EFFECTS OF SOME PLANT-DERIVED ANTITUMOR AGENTS (VINCRISTINE, COLCHICINE, MAYTANSINE, VP-16-213 AND VM-26) IN MICESIEBER SM; WHANG PENG J; BOTKIN C et al.1978; TERATOLOGY; USA; DA. 1978; VOL. 18; NO 1; PP. 31-48; BIBL. 1 P.Article

IN VITRO CYTOTOXICITY OF VP 16 ON PRIMARY TUMOR AND METASTASIS OF LEWIS LUNG CARCINOMAD'INCALCI M; ERBA E; VAGHI M et al.1982; EUR. J. CANCER CLIN. ONCOL.; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 4; PP. 377-380; BIBL. 11 REF.Article

ERFOLGREICHE BEHANDLUNG DES CHRONISCHEN MYELOMONOZYTAEREN LEUKAEMIE MIT VP 16-213 = EFFICACITE DU TRAITEMENT DE LA LEUCEMIE MYELOMONOCYTAIRE CHRONIQUE PAR LE VP 16213LABEDZKI L; ILLIGER HJ.1979; BLUT; DEU; DA. 1979; VOL. 38; NO 5; PP. 421-424; ABS. ENG; BIBL. 10 REF.Article

NEUE SUBSTANZEN IN DER ONKOLOGISCHEN THERAPIE. = NOUVEAUX PRODUITS EN CANCEROLOGIECAVALLI F.1978; SCHWEIZ. MED. WSCHR.; CHE; DA. 1978; VOL. 108; NO 32; PP. 1222-1227; ABS. ENG; BIBL. 62 REF.Article

COMPARISON OF THE HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, TWO ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES.ALLEN LM; CREAVEN PJ.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 10; PP. 697-707; BIBL. 2 P. 1/2Article

Identification of genomic regions contributing to etoposide-induced cytotoxicityBLEIBEL, Wasim K; DUAN, Shiwei; HUANG, R. Stephanie et al.Human genetics. 2009, Vol 125, Num 2, pp 173-180, issn 0340-6717, 8 p.Article

Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumorsSCOPECE, Luciano; FRANCESCHI, Enrico; CRINO, Lucio et al.Journal of neuro-oncology. 2006, Vol 79, Num 3, pp 299-305, issn 0167-594X, 7 p.Article

Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processingWHITMARSH, Ryan J; SAGINARIO, Charles; SLATER, Diana J et al.Oncogene (Basingstoke). 2003, Vol 22, Num 52, pp 8448-8459, issn 0950-9232, 12 p.Article

Electrochemical oxidation of anti-tumor agent, etoposideOBATA, R; OHNUMA, T.Chemical and pharmaceutical bulletin. 1993, Vol 41, Num 10, pp 1846-1847, issn 0009-2363Article

Spatial monitoring of toxicity in HMOX-LacZ transgenic miceYOUNG, Rachel; WOLF, C. Roland; BROWN, Ken et al.Transgenic research. 2010, Vol 19, Num 5, pp 897-902, issn 0962-8819, 6 p.Article

Mutagenicity of γ-radiation, mitomycin C, and etoposide in the Hprt and Tk genes of Tk^+/- miceDOBROVOLSKY, Vasily N; SHADDOCK, Joseph G; HEFLICH, Robert H et al.Environmental and molecular mutagenesis (Print). 2002, Vol 39, Num 4, pp 342-347, issn 0893-6692Article

PHASE II STUDY OF ETOPOSIDE IN THE TREATMENT OF ESOPHAGEAL CARCINOMA = ETUDE PHASE II DU VP16 DANS LE CARCINOME DE L'OESOPHAGECOONLEY CJ; BAINS M; HEELAN R et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 4; PP. 397-398; BIBL. 4 REF.; GRAPHArticle

EXPERIENCE OF THE NATIONAL CANCER INSTITUTE (USA) IN THE TREATMENT AND BIOLOGY OF SMALL CELL LUNG CANCERMINNA JD; BUNN PA JR; CARNEY DN et al.1982; BULL. CANCER; ISSN 0007-4551; FRA; DA. 1982; VOL. 69; NO 1; PP. 83-93; ABS. FRE; BIBL. 29 REF.Article

UNUSUAL REACTION TO VP-16-213 AND AVOIDANCE BY PROLONGED INFUSIONSUTHERLAND CM; LOUTFI A.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 2; PP. 409; BIBL. 4 REF.Article

ACUTE LEUKEMIA FOLLOWING INTENSIVE THERAPY FOR SMALL-CELL CARCINOMA OF THE LUNGMARKMAN M; PAVY MD; ABELOFF MD et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 4; PP. 672-675; BIBL. 15 REF.Article

ANALYSIS OF THE ANTICANCER DRUGS ETOPOSIDE (VP 16-213) AND TENIPOSIDE (VM 26) BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTIONSTRIFE RJ; JARDINE I; COLVIN M et al.1981; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1981; VOL. 224; NO 1; PP. 168-174; BIBL. 3 REF.Article

ANTIMETASTASIS EFFECT OF TWO DERIVATIVES OF EPIPODOPHYLLOTOXIN IN MICE.CATTAN A; POURNY C; CARPENTIER Y et al.1976; EUROP. J. CANCER; G.B.; DA. 1976; VOL. 12; NO 10; PP. 797-805; BIBL. 13 REF.Article

The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cellsZHIYING JI; LUOPING ZHANG; WEIHONG GUO et al.Mutagenesis. 2009, Vol 24, Num 4, pp 367-372, issn 0267-8357, 6 p.Article

VP-16 PLUS CYCLOPHOSPHAMIDE IN THE TREATMENT OF ADVANCED LUNG CANCER = ASSOCIATION VP-16 PLUS CYCLOPHOSPHAMIDE DANS LES TUMEURS AVANCEES DES BRONCHESESTAPE J; MILLA A; AGUSTI A et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 3; PP. 385-389; ABS. ENG; BIBL. 7 REF.; GRAPHArticle

DOXORUBICIN PLUS VP-16-213 FRO THE TREATMENT OF REFRACTORY BREAST CARCINOMAKONITS PH; VAN ECHO DA; AISNER J et al.1982; AMERICAN JOURNAL OF CLINICAL ONCOLOGY; ISSN 512273; USA; DA. 1982; VOL. 5; NO 5; PP. 515-519; BIBL. 15 REF.Article